{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/contraception-sterilization/how-up-to-date-is-this-topic/changes/","result":{"pageContext":{"chapter":{"id":"c63caa3e-3aaf-5b63-822c-8ececa2d150b","slug":"changes","fullItemName":"Changes","depth":2,"htmlHeader":"<!-- begin field 63a2a3a4-952e-4503-810a-0a097e673f3d --><h2>Changes</h2><!-- end field 63a2a3a4-952e-4503-810a-0a097e673f3d -->","summary":null,"htmlStringContent":"<!-- begin item 6160fef4-cdbd-41ed-a7c0-3429d1bb8de7 --><!-- begin field 3409a2c4-ed01-47ad-948c-0f7dba40b30b --><div><strong>April to June 2016</strong> — reviewed. A literature search was conducted in April 2016 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of the topic. Minor structural changes have been made to this topic.</div><!-- end field 3409a2c4-ed01-47ad-948c-0f7dba40b30b --><!-- end item 6160fef4-cdbd-41ed-a7c0-3429d1bb8de7 -->","topic":{"id":"8476bca2-26f3-58bf-9534-43bcd97620c4","topicId":"687784f1-c4f9-49e1-b81b-030c7fcf147a","topicName":"Contraception - sterilization","slug":"contraception-sterilization","lastRevised":"Last revised in June 2016","chapters":[{"id":"0a0eec74-d846-559b-9873-f4c72e00d5af","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"3180d0e4-2338-5fcd-b4b5-614d98f1acca","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"176d72c6-7d31-5475-9da0-78510905dad1","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"c63caa3e-3aaf-5b63-822c-8ececa2d150b","slug":"changes","fullItemName":"Changes"},{"id":"95258b7f-0b95-5dc0-8ffa-c171d269ba0a","slug":"update","fullItemName":"Update"}]},{"id":"81b04194-d074-5c40-ba4f-eaa5222ad594","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"d87fe99a-fa45-51e5-82fc-64ac4254370b","slug":"goals","fullItemName":"Goals"},{"id":"50d0b72e-30a1-5fe6-b65e-8d6fe12af0f7","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"2574066e-369c-54f1-9929-2706d8798924","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"1080840c-8b97-511c-b653-383403be4bf8","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"198a6919-897f-59e9-83d7-a78a592e6b9c","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - options for local implementation"},{"id":"7a718378-90fe-50b7-9256-240d1ab73099","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"99ee8781-8de8-517d-9a85-cbaf43b54009","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"28b2eb26-8068-5798-b284-630c74c6e068","slug":"definition","fullItemName":"Definition"}]},{"id":"e1a35d66-2974-5ebd-bd40-b9f9f6a4f455","fullItemName":"Management","slug":"management","subChapters":[{"id":"06f23be5-9ef5-57b0-ac71-f54f22f83fce","slug":"vasectomy","fullItemName":"Scenario: Vasectomy"},{"id":"189638ba-d294-56be-9c03-2d034c897672","slug":"tubal-occlusion","fullItemName":"Scenario: Tubal occlusion"}]},{"id":"22002e8b-15ca-5d82-9b91-ab290ae04082","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"283203e1-c2c2-50d1-9288-b5621f5d609b","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"78d7ee02-34ec-530f-816e-7eaba26a9b14","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"3fa88a6b-0352-5bc3-a220-8d595e4d36ab","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"9abe6ea7-de64-5ab7-ad5f-a8ce4daf5677","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"d293281e-afd9-5290-818c-49d8d8b45b9d","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"bb5349c5-7e0c-503f-9f1b-30814b72c0ae","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"9acf78a7-31d4-5a24-8e6e-93ab3cdaf074","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"176d72c6-7d31-5475-9da0-78510905dad1","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"569dd53e-511b-5350-aee2-6815e0f6e268","slug":"previous-changes","fullItemName":"Previous changes","depth":3,"htmlHeader":"<!-- begin field c0952d2e-6700-4cd1-915c-6485804db241 --><h3>Previous changes</h3><!-- end field c0952d2e-6700-4cd1-915c-6485804db241 -->","summary":null,"htmlStringContent":"<!-- begin item d0531dca-8ce5-4e73-9286-82c5a3692c6c --><!-- begin field f9f6abb5-d541-4017-9324-13465501ac3f --><p><strong>June 2013</strong> — minor update. The 2013 QOF options for local implementation have been added to this topic.</p><p><strong>March 2013</strong> — minor update. The telephone number for NHS Direct has been updated.</p><p><strong>February to June 2012</strong> — reviewed. A literature search was conducted in December 2011 to identify evidence-based guidelines, UK policy, systematic reviews, and key RCTs published since the last revision of the topic. No changes to clinical recommendations have been made. However, recommendations have been rewritten for clarity, and superseded guidelines and manufacturers' Summary of Product Characteristics have been updated accordingly.</p><p><strong>March 2011</strong> — topic structure revised to ensure consistency across CKS topics — no changes to clinical recommendations have been made.</p><p><strong>February 2010</strong> — updated to include the revised FSRH <em>UK Medical Eligibility Criteria</em> <em>for Contraceptive Use </em>(2010).</p><p><strong>March 2009</strong> — minor update. The Quality and Outcomes Framework (QOF) indicators for sexual health (2009) have been updated in the Goals and outcome measures section.</p><p><strong>April to September 2007</strong> — converted from CKS guidance to CKS topic structure. The evidence-base has been reviewed in detail, and recommendations are more clearly justified and transparently linked to the supporting evidence.</p><p><strong>July 2006</strong> — minor update. Information regarding orlistat and reduced efficacy of oral contraceptives included in drug interactions. </p><p><strong>January 2006 </strong>— minor update. Gynol II Jelly, Microval tablets and Duragel have been discontinued and the prescriptions have been removed. Black triangle removed from Cerazette®. </p><p><strong>October 2005</strong> — updated to include the new recommendations on missed pills from the Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit (2005). </p><p><strong>April 2005</strong> — minor update. Neogest® tablets have been discontinued and the prescriptions have been removed. Issued in April 2005.</p><p><strong>February 2005</strong> — updated to include prescribing advice from the Committee on Safety of Medicines (2005) on the effect of depot medroxyprogesterone acetate contraception on bones.</p><p><strong>September 2004</strong> — updated to include the WHO Medical Eligibilty Criteria relating to contraception for 2004 and recent licence changes to Cerazette®. Delfen® Contraceptive Foam is being discontinued at the end of October 2004 and the prescriptions have been removed. Issued in September 2004.</p><p><strong>January 2004</strong> — reviewed. Validated in March 2004 and issued in June 2004.</p><p><strong>January 2001</strong> — rewritten. Validated in March 2001 and issued in June 2001. Guidance on emergency contraception is no longer included in the Contraception guidance but can be found as a separate CKS topic.</p><p><strong>December 1997</strong> — written.</p><!-- end field f9f6abb5-d541-4017-9324-13465501ac3f --><!-- end item d0531dca-8ce5-4e73-9286-82c5a3692c6c -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}